Lawyers began selecting jurors to hear a lawsuit accusing healthcare giant Johnson & Johnson of liability for patient injuries allegedly caused by the company's transvaginal mesh implants.
MASSDEVICE ON CALL — A bellwether trial against Johnson & Johnson (NYSE:JNJ) began this month with lawyers beginning to select jurors to hear a lawsuit accusing the healthcare giant of liability patient injuries allegedly caused by the company's transvaginal mesh implants.
Plaintiff Linda Gross claims that J&J subsidiary Ethicon's Prolift implant left her with severe chronic pain that prevents her from working or even sitting.
Decisions made in this trial, which is taking place in New Jersey and expected to take about 2 months, may trickle down to similar lawsuits against C.R. Bard (NYSE:BCR), Endo Pharmaceuticals Holdings (NSDQ:ENDP) and Boston Scientific (NYSE:BSX).
Courts in West Virgina are slated in February to begin hearing cases against makers of transvaginal mesh implants, starting with a lawsuit against Bard.
J&J's Prolift device has been at the center of controversy over whether or not J&J marketed the device to doctors and patients without proper FDA approval.
Will the $66 billion buyout of Allergan by Actavis suck some of the juice out of Orange County, Calif...
Johnson & Johnson wants a federal judge to make Boston Scientific cough up some $7.2 billion - 40...
Boston Scientific goes down in another product liability lawsuit over its pelvic mesh products.
What's a medical device company to do when Facebook and Twitter can spread word of its products...